The Indian government has announced the development of new low-cost vaccine referred to as Rotavac against rotavirus, a diarrhea causative agent leading to a number of childhood deaths in the developing world. The new rotavirus vaccine is ...
Tags: Vaccine, Diarrhea Virus
Merck, referred to as MSD outside the US and Canada, has announced the FDA acceptance of biologics license application (BLA) of investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet for review. ...
Tags: Merck Biologics, Medicine
The European Commission has approved Sanofi Pasteur's 6-in-1 pediatric vaccine Hexyon/Hexacima (DTaP-IPV-Hib-HepB vaccine) for primary and booster vaccination of infants from six weeks of age. The EC decision follows the European ...
Tags: Pediatric Vaccine, Medicine
Omeros has filed an orphan drug application with the US FDA for OMS721, used to treat atypical hemolytic uremic syndrome (aHUS). OMS721 works by blocking the lectin pathway of the complement system while leaving intact the classical ...
Tags: Omeros, Orphan Drug, Medicine
The US FDA has accepted Merck's biologics license application (BLA) for an investigational allergy immunotherapy tablet (AIT), Timothy grass pollen (Phleum pratense). The application includes safety and efficacy data of the ...
Tags: FDA, Merck Bla, Allergy Immunotherapy Tablet
Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK government-backed Biomedical Catalyst (BBC) for the pre-clinical development of pneumococcal vaccine PnuBioVax. The pharma company ...
Provectus Pharmaceuticals has announced the commencement of Phase 1 study of PV-10 injection to elucidate bystander effect at the Moffitt Cancer Center. The study is designed to assess the possible immune biomarkers in both tumor tissue ...
Tags: Provectus, injection, immune biomarkers, PV 10 injection
Boulder Diagnostics, a developer of new diagnostic technologies, has launched Lyme Borreliosis disease test as a diagnostic service in Europe. The SpiroFind test, which is offered by the company's clinical diagnostic service ...
Tags: clinical trial, diagnostic technology, Boulder Diagnostics
The Sanofi vaccines division Sanofi Pasteur has launched Japanese encephalitis (JE) vaccine, IMOJEV, in Australia. Australian Health Authorities approved the live-attenuated JE vaccine for people aged 12 months and older, based on data ...
Tags: Australian Health Authorities, Japanese encephalitis, vaccine, JE vaccine
Fraunhofer Center for Molecular Biotechnology (FhCMB) has received a contract from the US National Institute of Allergy and Infectious Diseases to develop vaccine technologies for advancing the next generation of anthrax vaccines. ...
Tags: FhCMB, anthrax vaccines, NIH
Theravectys has received regulatory clearances from France's National Security Agency and Belgium's Federal Agency for Medicines and Health Products to commence a phase I/II clinical trial of its anti-HIV therapeutic vaccine. Using the ...
Tags: Theravectys, HIV positive patients, anti-HIV therapeutic vaccine
US Department of Defense has granted a Congressionally Directed Medical Research Programs (CDMRP) grant to Aduro BioTech to complete the preclinical development of a new therapeutic cancer vaccine for prostate cancer. Aduro's cancer ...
Tags: Aduro, cancer vaccine platform, IND
Immunovaccine has reported a net loss of $1.7m for the third quarter ended 30 September 2012 compared to a net loss of $1.5m for the same quarter in 2011. According to the company the increased loss is due to the $155,000 increase in ...
Tags: Net Loss, therapeutic cancer vaccine, immune enhancement technology
Cytori Therapeutics has treated first US patient in the ATHENA trial using the company's cell therapy based on patient's own adipose-derived stem and regenerative cells (ADRCs). ADRCs are processed using the company's proprietary Celution ...
Vaxxas, a developer of vaccine-delivery technology, has named David Hoey as the company's new chief executive officer (CEO). The vaccine-delivery technology is designed for activating immunological cells which are located immediately ...